Aquatic Capital Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
153,665
+98,527
+179% +$883K 0.05% 458
2026
Q1
$449K Sell
55,138
-43,211
-44% -$392K 0.01% 786
2025
Q4
$661K Buy
+98,349
New +$741K 0.02% 665
2022
Q3
– Sell
-7,900
Closed -$406K – 1439
2022
Q2
$406K Buy
+7,900
New +$409K 0.13% 197

Other funds holding NVAX

Aquatic Capital Management's NVAX Position: Q2 2026 in Review

Aquatic Capital Management increased its Novavax (NVAX) stake by 179% in Q2 2026, buying an estimated $883K and bringing the position to 153,665 shares worth $1.45M. The position accounts for 0.05% of the portfolio, ranked #458.

Aquatic Capital Management first reported a position in NVAX in Q2 2022 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Aquatic Capital Management held 153,665 shares of Novavax worth $1.45M as of Q2 2026.
  • Aquatic Capital Management bought 98,527 Novavax shares in Q2 2026, an estimated $883K.
  • Novavax made up 0.05% of Aquatic Capital Management's portfolio in Q2 2026, its #458 holding.
  • Aquatic Capital Management first reported a position in Novavax in Q2 2022 and has held it in 4 quarters since.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.